259 related articles for article (PubMed ID: 16784493)
1. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
[TBL] [Abstract][Full Text] [Related]
2. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
Sasaki N; Kurose A; Inoue H; Sawai T
Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
[TBL] [Abstract][Full Text] [Related]
3. Immunological analysis of pulmonary hypertension in connective tissue diseases.
Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
[TBL] [Abstract][Full Text] [Related]
4. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
5. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
[TBL] [Abstract][Full Text] [Related]
6. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms.
Bodolay E; Csipo I; Gál I; Sipka S; Gyimesi E; Szekanecz Z; Szegedi G
Clin Exp Rheumatol; 2004; 22(4):409-15. PubMed ID: 15301236
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.
Soltesz P; Bereczki D; Szodoray P; Magyar MT; Der H; Csipo I; Hajas A; Paragh G; Szegedi G; Bodolay E
Arthritis Res Ther; 2010; 12(3):R78. PubMed ID: 20459625
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of survival in mixed connective tissue disease (MCTD)].
Bodolay E; Gaál J; Végh J; Soltész P; Szodoray P; Lakos G; Nemes Z; Dezsö B; Szegedi G
Orv Hetil; 2002 Nov; 143(45):2543-8. PubMed ID: 12501560
[TBL] [Abstract][Full Text] [Related]
13. Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension.
Satoh T; Kimura K; Okano Y; Hirakata M; Kawakami Y; Kuwana M
Rheumatology (Oxford); 2005 Feb; 44(2):192-6. PubMed ID: 15509626
[TBL] [Abstract][Full Text] [Related]
14. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue disease.
Naniwa T; Sugiura Y; Banno S; Yoshinouchi T; Matsumoto Y; Ueda R
Clin Exp Rheumatol; 2007; 25(4):593-8. PubMed ID: 17888216
[TBL] [Abstract][Full Text] [Related]
16. Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease.
Lage LV; de Carvalho JF; Caleiro MT; Yoshinari NH; da Mota LM; Khamashta MA; Cossermelli W
Isr Med Assoc J; 2012 Feb; 14(2):84-7. PubMed ID: 22693786
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
18. Diastolic function of the heart in mixed connective tissue disease.
Végh J; Hegedus I; Szegedi G; Zeher M; Bodolay E
Clin Rheumatol; 2007 Feb; 26(2):176-81. PubMed ID: 16865311
[TBL] [Abstract][Full Text] [Related]
19. Clinical course, prognosis, and causes of death in mixed connective tissue disease.
Hajas A; Szodoray P; Nakken B; Gaal J; Zöld E; Laczik R; Demeter N; Nagy G; Szekanecz Z; Zeher M; Szegedi G; Bodolay E
J Rheumatol; 2013 Jul; 40(7):1134-42. PubMed ID: 23637328
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of mixed connective tissue disease.
Lundberg IE
Rheum Dis Clin North Am; 2005 Aug; 31(3):535-47, vii-viii. PubMed ID: 16084324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
